The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Ivanova S.A.

Nauchno-issledovatel'skiĭ institut psikhicheskogo zdorov'ia Sibirskogo otdeleniia Rossiĭskoĭ akademii meditsinskikh nauk, Tomsk

Alifirova V.M.

Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet, Tomsk, Russia

Zhukova I.A.

Siberian State Medical University, Tomsk

Boyko A.S.

Mental Health Research Institute, Tomsk

Fedorenko O.Iu.

Nauchno-issledovatel'skiĭ institut psikhicheskogo zdorov'ia Sibirskogo otdeleniia Rossiĭskoĭ akademii meditsinskikh nauk, Tomsk;
Natsional'nyĭ issledovatel'skiĭ Tomskiĭ politekhnicheskiĭ universitet, Tomsk

Zhukova N.G.

Siberian State Medical University, Tomsk, Russia

Bokhan N.A.

Nauchno-issledovatel'skiĭ institut psikhicheskogo zdorov'ia Tomskogo nauchnogo tsentra Sibirskogo otdeleniia RAMN

The association of the DRD3 gene with Parkinson’s disease

Authors:

Ivanova S.A., Alifirova V.M., Zhukova I.A., Boyko A.S., Fedorenko O.Iu., Zhukova N.G., Bokhan N.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(5): 71‑74

DOI: 10.17116/jnevro20161165171-74

Views: 1069

Downloaded: 17

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Ivanova SA, Alifirova VM, Zhukova IA, Boyko AS, Fedorenko OIu, Zhukova NG, Bokhan NA. The association of the DRD3 gene with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(5):71‑74. (In Russ.)
https://doi.org/10.17116/jnevro20161165171-74

 
МСФ на ЯМ
Close metadata
Recommended articles:
Criteria of syndrome frailty in Parkinson´s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):52-56
Tremor-dominant form of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):28-35
Nocturia in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):48-54
Asso­ciations of serum neuromarkers with clinical features of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):145-152
The asso­ciation of single-nucleotide poly­morphism rs6265 of the brain-derived neurotrophic factor gene with clinical features in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):82-88
Sarcopenia as a non-motor symptom of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):15-22
Asso­ciation of inflammation and chro­nic fati­gue syndrome in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):79-87
Electric acti­vity of the brain at early and late clinical stages of expe­rimental mode­ling of Parkinson’s disease, an impact of hema­ntane. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):129-134
Diagnosis and treatment approaches for sialorrhea in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):29-34
Problems in orga­nizing neurosurgical care for patients with Parkinson’s disease in the Russian Fede­ration. Burdenko's Journal of Neurosurgery. 2024;(3):5-13

Objective. To investigate the association between dopamine receptor DRD3 gene tag single nucleotide polymorphisms (SNPs) and the risk of Parkinson’s disease (PD). Material and methods. One hundred and forty-three patients with PD and 96 healthy individuals from the Russian population were examined. Ten tag SNPs (rs963468, rs2134655, rs9817063, rs324035, rs11721264, rs1800828, rs3773678, rs167770, rs167771, rs7633291) within DRD3 have been genotyped. Results and conclusion. Associations between 4 polymorphisms (rs11721264, rs3773678, rs167771, rs324035) and PD have been found. Our study confirms the involvement of polymorphic features of dopamine receptors genes in the pathophysiology in PD.

Keywords:

Parkinson’s disease
tag single nucleotide polymorphisms
gene DRD3

Authors:

Ivanova S.A.

Nauchno-issledovatel'skiĭ institut psikhicheskogo zdorov'ia Sibirskogo otdeleniia Rossiĭskoĭ akademii meditsinskikh nauk, Tomsk

Alifirova V.M.

Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet, Tomsk, Russia

Zhukova I.A.

Siberian State Medical University, Tomsk

Boyko A.S.

Mental Health Research Institute, Tomsk

Fedorenko O.Iu.

Nauchno-issledovatel'skiĭ institut psikhicheskogo zdorov'ia Sibirskogo otdeleniia Rossiĭskoĭ akademii meditsinskikh nauk, Tomsk;
Natsional'nyĭ issledovatel'skiĭ Tomskiĭ politekhnicheskiĭ universitet, Tomsk

Zhukova N.G.

Siberian State Medical University, Tomsk, Russia

Bokhan N.A.

Nauchno-issledovatel'skiĭ institut psikhicheskogo zdorov'ia Tomskogo nauchnogo tsentra Sibirskogo otdeleniia RAMN

List of references:

  1. Zhukova IA, Zhukova NG, Alifirova VM, Gashilova FF. Kognitivnye rasstrojstva i kachestvo zhizni pacientov s bolezn'ju Parkinsona. Bjulleten' sibirskoj mediciny. 2008;7:5(1):145-149. (In Russ.).
  2. Illarioshkin SN, Levin OS. Bolezn' Parkinsona i rasstrojstva dvizhenij. M.: ZAO «RKI Sovero press»; 2014. (In Russ.).
  3. Jahno NN, Shtul'man DR. Bolezni nervnoj sistemy. M.: Medicina; 2001. (In Russ.).
  4. Alonso-Navarro H, Javier Jimenez-Jimenez F, Garcia-Martin E, AG Agundez J. Genomic and pharmacogenomic biomarkers of Parkinson’s disease. Current drug metabolism. 2014;15(2):129-181.  doi: 10.2174/138920021502140327175404.
  5. Subramaniam SR, Chesselet M-F. Mitochondrial dysfunction and oxidative stress in Parkinson’s disease. Progress in neurobiology. 2013;106:17-32.  doi: 10.1016/j.pneurobio.2013.04.004.
  6. Shadrina MI, Slominskij PA. Znachenie mitohondrial'noj disfunkcii i okislitel'nyh povrezhdenij v molekuljarnoj patologii bolezni Parkinsona. Molekuljarnaja biologija. 2008;42:5:809-819. (In Russ.).
  7. Bekris LM, Mata IF, Zabetian CP. The genetics of Parkinson’s disease. J. of geriatric psychiatry and neurology. 2010;23(4):228-242.  doi: 10.1177/0891988710383572.
  8. Illarioshkin SN, Ivanova-Smolenskaja IA, Markova ED, Shadrina MI, Kljushnikov SA, Zagorovskaja TB, Miklina NI, Slominskij PA, Limborskaja SA. Molekuljarno-geneticheskij analiz nasledstvennyh nejrodegenerativnyh zabolevanij. Genetika. 2004;40:6:816-826. (In Russ.).
  9. Hauser DN, Hastings TG. Mitochondrial dysfunction and oxidative stress in Parkinson’s disease and monogenic parkinsonism. Neurobiology of disease. 2013;51:35-42.  doi: 10.1016/j.nbd.2012.10.011.
  10. Xu Z, Taylor JA. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic acids research. 2009;37(suppl 2):600-605.  doi: 10.1093/nar/gkp290.
  11. Dai D, Wang Y, Wang L et al. Polymorphisms of DRD2 and DRD3 genes and Parkinson’s disease: A meta-analysis. Biomedical reports. 2014;2(2):275-281.  doi: 10.3892/br.2014.220.
  12. Thompson J, Thomas N, Singleton A et al. D2 dopamine receptor gene (DRD2) Taql A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics and Genomics. 1997;7(6):45-54. http://journals.lww.com/jpharmacogenetics/Fulltext/1997/12000/D2_dopamine_receptor_gene__DRD2__Taql_A.6.aspx. doi: 10.1097/00008571-199712000-00006.
  13. Hadithy AAl, Ivanova S, Pechlivanoglou P et al. Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2009;33(3):475-481.  doi: 10.1016/j.pnpbp.2009.01.010.
  14. Loonen AJ, Ivanova SA. New insights into the mechanism of drug-induced dyskinesia. CNS spectrums. 2013;18(01):15-20.  doi: 10.1017/S1092852912000752.
  15. McGuire V, Van Den Eeden S, Tanner C et al. Association of DRD2 and DRD3 polymorphisms with Parkinson’s disease in a multiethnic consortium. J of the neurological sciences. 2011;307(1):22-29.  doi: 10.1016/j.jns.2011.05.031.
  16. Wang J, Liu Z-L, Chen B. Polymorphisms of dopamine D3-receptor gene and parkinson disease. Chinese Journal of New Drugs and Clinical Remedies. 2000;19(2):108-110.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.